Work

Supplementary Figure S2 from A MET Targeting Antibody–Drug Conjugate Overcomes Gemcitabine Resistance in Pancreatic Cancer

Year: 2023

Type: supplementary-materials

Abstract: Dose dependent anti-proliferative effect of TR1801-ADC

DOI: 10.1158/1078-0432.22482248

Authors: Alex Cazes, Oscar Betancourt, Edgar Esparza, Evangeline S. Mose, Dawn Jaquish, Eric Wong, Alexis A. Wascher, Hervé Tiriac, Marco Gymnopoulos, Andrew M. Lowy

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361814543

Cites:

Cited by:

Related to: 10